Research Article
Nomogram for Predicting Survival in Advanced Gastric Cancer after Neoadjuvant Chemotherapy and Radical Surgery
Table 1
Patient characteristics, hazard ratios, and
values from univariable survival analysis (
).
| | (%) | Hazard ratio (95% CI) | value |
| Age (years) | | | | <60 | 113 (52.6%) | Reference | — | ≥60 | 102 (47.4%) | 2.34 (1.23-4.46) | 0.01 | Sex | | | | Male | 167 (77.7%) | Reference | — | Female | 48 (22.3%) | 1.49 (0.75-2.94) | 0.26 | BMI (kg/m2) | | 0.99 (0.89-1.11) | 0.87 | 0-24 | 173 (80.5%) | Reference | — | >24 | 42 (19.5%) | 0.73 (0.31-1.75) | 0.48 | Location | | | | Upper | 85 (39.5%) | Reference | — | Middle | 38 (17.7%) | 0.96 (0.40-2.31) | 0.93 | Lower | 85 (39.5%) | 0.73 (0.36-1.47) | 0.38 | Whole | 7 (3.3%) | 0.005 (0-10+) | 0.72 | Tumor grade | | | | G3 | 151 (70.2%) | Reference | — | G2 | 56 (26%) | 0.78 (0.38-1.62) | 0.51 | G1 | 8 (3.7%) | 0.006 (0-10+) | 0.65 | Clinical T stage | | | | cT3 | 109 (50.7%) | Reference | — | cT4 | 106 (49.3%) | 1.61 (0.83-3.16) | 0.16 | Clinical N staging | | | | cN0 | 5 (2.3%) | Reference | — | cN+ | 210 (97.7%) | 1.61 (0.21-12.21) | 0.645 |
|
|